Tergus Pharma and MedPharm are now one company!
+
The two premier topical experts have joined forces to create the world’s leading topical CDMO with global reach, experienced leadership, strong financial backing, and expanded end-to-end capabilities from early stage development through full commercial production of topical drug products.
Click here for the official press release.
Our very own VP of US Operations Jon Lenn has been working on some pretty exciting research that expands the boundaries of large RNA Aptamer molecules suitable for topical treatment.
Please use the link below to gain access to the paper.